|Daily low-dose aspirin? Rethink its risks vs. benefits, experts advise
Aspirin may not be the easy, cheap, daily wonder drug that doctors once thought it might be: New research has led medical experts to rethink and caution against the low-dose regimen followed by tens o … Continue Reading
|As Delta surge eases, what’s next with this pandemic?
As the summer’s deadly Delta variant surge slowly seems to be receding, questions are rising anew as to what further harms the coronavirus pandemic may inflict on a nation that already has suffered gr … Continue Reading
|Aching backs lead to dubious surgeries and billion$ in revenue$
As the nation rapidly grays, not only are middle-aged and older patients undergoing increasing numbers of knee, hip, ankle, and shoulder surgeries, back operations also have spiked — and a significant … Continue Reading
|Nothing to see here? Consultant advises drug makers — and their regulators
When Big Pharma gets jammed up by federal regulators overseeing what may be risky prescription drugs, what to do? How about hiring the help of a powerful, secretive business consulting company — which … Continue Reading
|Will Congress bog down or will it act on people’s health and other needs?
It may be tempting to get caught up in cynical views of congressional lawmaking, budgeting, and spending — seeing it as gross “sausage making” or in sporting “who wins and who loses” score-keeping. Bu … Continue Reading